Works by Adachi, Takahiro


Results: 42
    1
    2
    3

    Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact.

    Published in:
    World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05507-6
    By:
    • Fukushima, Tatsuo;
    • Tsujino, Takuya;
    • Sakamoto, Moritoshi;
    • Takahara, Kiyoshi;
    • Komura, Kazumasa;
    • Yanagisawa, Takafumi;
    • Mori, Keiichiro;
    • Fukuokaya, Wataru;
    • Urabe, Fumihiko;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Saruta, Masanobu;
    • Yoshizawa, Atsuhiko;
    • Toyoda, Shingo;
    • Kawada, Tatsushi;
    • Katayama, Satoshi;
    • Iwatsuki, Kengo;
    • Nakamura, Ko;
    • Nishio, Kyosuke;
    • Nishimura, Kazuki
    Publication type:
    Article
    4

    Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases.

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 457, doi. 10.1159/000534554
    By:
    • Nishio, Kyosuke;
    • Higashio, Takuya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Tsuchida, Shuya;
    • Matsuda, Takuya;
    • Tsujino, Takuya;
    • Nishimura, Kazuki;
    • Tokushige, Satoshi;
    • Nakamori, Keita;
    • Uchimoto, Taizo;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Commensal-bacteria-derived butyrate promotes the T-cell-independent IgA response in the colon.

    Published in:
    International Immunology, 2020, v. 32, n. 4, p. 243, doi. 10.1093/intimm/dxz078
    By:
    • Isobe, Junya;
    • Maeda, Shintarou;
    • Obata, Yuuki;
    • Iizuka, Keito;
    • Nakamura, Yutaka;
    • Fujimura, Yumiko;
    • Kimizuka, Tatsuki;
    • Hattori, Kouya;
    • Kim, Yun-Gi;
    • Morita, Tatsuya;
    • Kimura, Ikuo;
    • Offermanns, Stefan;
    • Adachi, Takahiro;
    • Nakao, Atsuhito;
    • Kiyono, Hiroshi;
    • Takahashi, Daisuke;
    • Hase, Koji
    Publication type:
    Article
    15

    C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 4, p. 635, doi. 10.1007/s11523-024-01068-7
    By:
    • Uchimoto, Taizo;
    • Matsuda, Takuya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Hashimoto, Mamoru;
    • Higashio, Takuya;
    • Tsuchida, Shuya;
    • Nishimura, Kazuki;
    • Tsujino, Takuya;
    • Nakamura, Ko;
    • Fukushima, Tatsuo;
    • Nishio, Kyosuke;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko
    Publication type:
    Article
    16

    Durable Response to Enfortumab Vedotin Compared to Re-challenging Chemotherapy in Metastatic Urothelial Carcinoma After Checkpoint Inhibitors.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 3, p. 401, doi. 10.1007/s11523-024-01047-y
    By:
    • Uchimoto, Taizo;
    • Tsuchida, Shuya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Hashimoto, Mamoru;
    • Higashio, Takuya;
    • Matsuda, Takuya;
    • Nishimura, Kazuki;
    • Tsujino, Takuya;
    • Nakamura, Ko;
    • Fukushima, Tatsuo;
    • Nishio, Kyosuke;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko
    Publication type:
    Article
    17

    Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study.

    Published in:
    International Journal of Urology, 2024, v. 31, n. 4, p. 342, doi. 10.1111/iju.15368
    By:
    • Fukuokaya, Wataru;
    • Koike, Yuhei;
    • Yata, Yuji;
    • Komura, Kazumasa;
    • Uchimoto, Taizo;
    • Tsujino, Takuya;
    • Saruta, Masanobu;
    • Takahara, Kiyoshi;
    • Fujita, Kazutoshi;
    • Minami, Takafumi;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Ohno, Yoshio;
    • Uemura, Hirotsugu;
    • Shiroki, Ryoichi;
    • Azuma, Haruhito;
    • Kimura, Takahiro
    Publication type:
    Article
    18

    Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma.

    Published in:
    BJU International, 2023, v. 131, n. 4, p. 477, doi. 10.1111/bju.15893
    By:
    • Uchimoto, Taizo;
    • Fukushima, Tatsuo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Nakamura, Ko;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Nishio, Kyosuke;
    • Nakamori, Keita;
    • Iwatani, Kosuke;
    • Yamamoto, Shutaro;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi;
    • Tsuduki, Shunsuke;
    • Takahara, Kiyoshi;
    • Inamoto, Teruo
    Publication type:
    Article
    19
    20

    Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 4, p. 1, doi. 10.1007/s00432-024-05717-2
    By:
    • Yosuke Hirasawa;
    • Takahiro Adachi;
    • Takeshi Hashimoto;
    • Wataru Fukuokaya;
    • Yuhei Koike;
    • Yuji Yata;
    • Kazumasa Komura;
    • Taizo Uchimoto;
    • Takuya Tsujino;
    • Kazuki Nishimura;
    • Kiyoshi Takahara;
    • Masanobu Saruta;
    • Kazutoshi Fujita;
    • Mamoru Hashimoto;
    • Hirotsugu Uemura;
    • Ryoichi Shiroki;
    • Takashi Azuma;
    • Takahiro Kimura;
    • Yoshio Ohno
    Publication type:
    Article
    21

    Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.

    Published in:
    World Journal of Urology, 2023, v. 41, n. 12, p. 3585, doi. 10.1007/s00345-023-04687-3
    By:
    • Tsujino, Takuya;
    • Komura, Kazumasa;
    • Inamoto, Teruo;
    • Maenosono, Ryoichi;
    • Hashimoto, Takeshi;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Tokushige, Satoshi;
    • Ohno, Takaya;
    • Yamazaki, Shogo;
    • Fukushima, Tatsuo;
    • Nakamura, Ko;
    • Yano, Yusuke;
    • Nishimura, Kazuki;
    • Kinoshita, Shoko;
    • Nakamori, Keita;
    • Tsutsumi, Takeshi;
    • Matsunaga, Tomohisa;
    • Yoshikawa, Yuki;
    • Uchimoto, Taizo
    Publication type:
    Article
    22

    Real‑world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration‐resistant prostate cancer.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 19, p. 19414, doi. 10.1002/cam4.6536
    By:
    • Tsujino, Takuya;
    • Tokushige, Satoshi;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Ohno, Takaya;
    • Nakamori, Keita;
    • Maenosono, Ryoichi;
    • Nishimura, Kazuki;
    • Yamazaki, Shogo;
    • Uchimoto, Taizo;
    • Yanagisawa, Takafumi;
    • Mori, Keiichiro;
    • Urabe, Fumihiko;
    • Tsuzuki, Shunsuke;
    • Iwatani, Kosuke
    Publication type:
    Article
    23
    24

    Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 12, p. 1336, doi. 10.1093/jjco/hyae108
    By:
    • Toyoda, Shingo;
    • Fukuokaya, Wataru;
    • Mori, Keiichiro;
    • Kawada, Tatsushi;
    • Katayama, Satoshi;
    • Nishimura, Shingo;
    • Maenosono, Ryoichi;
    • Tsujino, Takuya;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Saruta, Masanobu;
    • Komura, Kazumasa;
    • Nukaya, Takuhisa;
    • Yanagisawa, Takafumi;
    • Takahara, Kiyoshi;
    • Hashimoto, Takeshi;
    • Azuma, Haruhito;
    • Ohno, Yoshio;
    • Shiroki, Ryoichi;
    • Araki, Motoo
    Publication type:
    Article
    25
    26
    27
    28
    29

    Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 4, p. 761, doi. 10.1007/s10147-025-02709-1
    By:
    • Uchimoto, Taizo;
    • Iwatsuki, Kengo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Hashimoto, Mamoru;
    • Minami, Takafumi;
    • Yamamoto, Yutaka;
    • Yamazaki, Shogo;
    • Takai, Tomoaki;
    • Sakamoto, Moritoshi;
    • Nakajima, Yuki;
    • Nishimura, Kazuki;
    • Maenosono, Ryoichi;
    • Tsujino, Takuya;
    • Nakamura, Ko
    Publication type:
    Article
    30

    Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 123, doi. 10.1007/s10147-024-02649-2
    By:
    • Uchimoto, Taizo;
    • Iwatsuki, Kengo;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Saruta, Masanobu;
    • Fujimoto, Saizo;
    • Minami, Takafumi;
    • Yamamoto, Yutaka;
    • Yamazaki, Shogo;
    • Takai, Tomoaki;
    • Sakamoto, Moritoshi;
    • Nakajima, Yuki;
    • Nishimura, Kazuki;
    • Maenosono, Ryoichi;
    • Tsujino, Takuya;
    • Nakamura, Ko
    Publication type:
    Article
    31
    32

    Serum C-reactive Protein Level Predicts Overall Survival for Clear Cell and Non-Clear Cell Renal Cell Carcinoma Treated with Ipilimumab plus Nivolumab.

    Published in:
    Cancers, 2022, v. 14, n. 22, p. 5659, doi. 10.3390/cancers14225659
    By:
    • Yano, Yusuke;
    • Ohno, Takaya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Uchimoto, Taizo;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Yamazaki, Shogo;
    • Tokushige, Satoshi;
    • Nishimura, Kazuki;
    • Tsujino, Takuya;
    • Nakamori, Keita;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi;
    • Tsuduki, Shunsuke
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40

    CD22 serves as a receptor for soluble IgM.

    Published in:
    European Journal of Immunology, 2012, v. 42, n. 1, p. 241, doi. 10.1002/eji.201141899
    By:
    • Adachi, Takahiro;
    • Harumiya, Satoru;
    • Takematsu, Hiromu;
    • Kozutsumi, Yasunori;
    • Wabl, Matthias;
    • Fujimoto, Manabu;
    • Tedder, Thomas F.
    Publication type:
    Article
    41
    42

    Prognostic Impact of Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab: A Multicenter Retrospective Study.

    Published in:
    Clinical Genitourinary Cancer, 2024, v. 22, n. 1, p. 76, doi. 10.1016/j.clgc.2023.09.007
    By:
    • Takuhisa Nukaya;
    • Kiyoshi Takahara;
    • Atsuhiko Yoshizawa;
    • Masanobu Saruta;
    • Yusuke Yano;
    • Takaya Ohno;
    • Taizo Uchimoto;
    • Wataru Fukuokaya;
    • Takahiro Adachi;
    • Shogo Yamazaki;
    • Satoshi Tokushige;
    • Kazuki Nishimura;
    • Takuya Tsujino;
    • Keita Nakamori;
    • Shutaro Yamamoto;
    • Kosuke Iwatani;
    • Fumihiko Urabe;
    • Keiichiro Mori;
    • Takafumi Yanagisawa;
    • Shunsuke Tsuduki
    Publication type:
    Article